Posted by Michael Wonder on 31 Jan 2022
MSAC publishes updated agenda for upcoming meeting
28 January 2022 - 11 agenda items for consideration at the 31 March - 1 April 2022 meeting.
The assessments of note are:
- Whole genome sequencing of antimicrobial-resistant pathogens (1646)
- KRAS G12C variant testing to determine eligibility for PBS subsidised sotorasib for the second-line treatment of patients with locally advanced or metastatic non small-cell lung cancer (1669)
- Procedures for the implantation and refill-exchange of the port delivery system with ranibizumab to treat patients with neovascular age-related macular degeneration (1695)
